Literature DB >> 22890811

Reliability of postmortem fentanyl concentrations in determining the cause of death.

James R Gill1, Peter T Lin, Lewis Nelson.   

Abstract

INTRODUCTION: Transdermal fentanyl, an opioid used for management of marked pain, also is abused and may cause death.
METHODS: We reviewed medical examiner reports of 92 decedents who had one or more fentanyl transdermal patches on their body and had fentanyl detected in their postmortem toxicology analysis.
RESULTS: The manners of death included 40 accidents, 36 natural, 8 suicides, 5 therapeutic complications, and 3 undetermined deaths. Among the accidental fentanyl intoxication deaths, 32 of 37 involved substance abuse. The majority (95 %) of the 37 accidental deaths involving fentanyl were multi-drug intoxications. The substance abuse deaths had a mean fentanyl blood concentration (26.4 ng/ml or μg/L) that was over twice that of the natural group (11.8 ng/ml). Our analysis suggests a relationship between total patch dosage and mean postmortem fentanyl concentration up to the 100-μg/h dose.
CONCLUSIONS: The very wide and overlapping ranges of postmortem fentanyl concentrations effectively nullify the utility of correlating the dose and expected postmortem concentration for any particular death. Based on the variable relationship between dose and blood concentration, the antemortem dose cannot be reliably predicted based on the postmortem concentration. This does not, however, render the medical examiner/coroner unable to determine the cause and manner of death because the toxicology results are only one datum point among several that are considered. Although there was a weakly positive relationship between body mass index and fentanyl concentration, further research is needed to determine whether adipose tissue represents a significant depot for postmortem release of fentanyl.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22890811      PMCID: PMC3576505          DOI: 10.1007/s13181-012-0253-z

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  29 in total

1.  Complications of oral exposure to fentanyl transdermal delivery system patches.

Authors:  Jane M Prosser; Brent E Jones; Lewis Nelson
Journal:  J Med Toxicol       Date:  2010-12

2.  Use of "therapeutic complication" as a manner of death.

Authors:  James R Gill; Lara B Goldfeder; Charles S Hirsch
Journal:  J Forensic Sci       Date:  2006-09       Impact factor: 1.832

3.  A toxicology-based review of fentanyl-related deaths in New Mexico (1986-2007).

Authors:  Clarissa S Krinsky; Sarah L Lathrop; Michael Crossey; Ginger Baker; Ross Zumwalt
Journal:  Am J Forensic Med Pathol       Date:  2011-12       Impact factor: 0.921

Review 4.  Fentanyl in postmortem forensic toxicology.

Authors:  Robert B Palmer
Journal:  Clin Toxicol (Phila)       Date:  2010-10       Impact factor: 4.467

5.  Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application.

Authors:  Hilke Andresen; Annemarie Gullans; Michele Veselinovic; Sven Anders; Achim Schmoldt; Stefanie Iwersen-Bergmann; Alexander Mueller
Journal:  J Anal Toxicol       Date:  2012-04       Impact factor: 3.367

6.  Postmortem redistribution of fentanyl in blood.

Authors:  Kalen N Olson; Kristin Luckenbill; Jonathan Thompson; Owen Middleton; Roberta Geiselhart; Kelly M Mills; Julie Kloss; Fred S Apple
Journal:  Am J Clin Pathol       Date:  2010-03       Impact factor: 2.493

7.  Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004).

Authors:  Teri L Martin; Karen L Woodall; Barry A McLellan
Journal:  J Anal Toxicol       Date:  2006-10       Impact factor: 3.367

Review 8.  Transdermal fentanyl: pharmacology and toxicology.

Authors:  Lewis Nelson; Robert Schwaner
Journal:  J Med Toxicol       Date:  2009-12

9.  Deaths with transdermal fentanyl patches.

Authors:  Mary I Jumbelic
Journal:  Am J Forensic Med Pathol       Date:  2010-03       Impact factor: 0.921

Review 10.  Fatal overdose due to prescription fentanyl patches in a patient with sickle cell/beta-thalassemia and acute chest syndrome: A case report and review of the literature.

Authors:  Olaf J Biedrzycki; David Bevan; Sebastian Lucas
Journal:  Am J Forensic Med Pathol       Date:  2009-06       Impact factor: 0.921

View more
  6 in total

1.  Toxicological testing when evaluating fatal cases suspected of acute fentanyl toxicity.

Authors:  Xiulu Ruan; Srinivas Chiravuri; Alan D Kaye
Journal:  Forensic Sci Med Pathol       Date:  2016-07-07       Impact factor: 2.007

2.  Postmortem Toxicology Findings of Acetyl Fentanyl, Fentanyl, and Morphine in Heroin Fatalities in Tampa, Florida.

Authors:  Julia Pearson; Justin Poklis; Alphonse Poklis; Carl Wolf; Mary Mainland; Laura Hair; Kelly Devers; Leszek Chrostowski; Elise Arbefeville; Michele Merves
Journal:  Acad Forensic Pathol       Date:  2015-12

Review 3.  From Death to Death Certificate: What do the Dead say?

Authors:  James R Gill
Journal:  J Med Toxicol       Date:  2016-05-02

4.  Acute stressors and clinical characteristics differentiate death by suicide, accident, or natural causes among illicit and prescription opiate users.

Authors:  Alison J Athey; Eleanor E Beale; James C Overholser; Craig A Stockmeier; Courtney L Bagge
Journal:  Drug Alcohol Depend       Date:  2020-01-11       Impact factor: 4.492

5.  Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.

Authors:  Ronald B Moss; Meghan McCabe Pryor; Rebecca Baillie; Katherine Kudrycki; Christina Friedrich; Mike Reed; Dennis J Carlo
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

6.  Surge in Fentanyl Toxicity Deaths in Jefferson Parish, LA, 2013-2018.

Authors:  Kayla Noto; Dana Troxclair; Melva Williams; Ronda Conners; Erin Mathes; Mark Bone; Gerry Cvitanovich
Journal:  Ochsner J       Date:  2019
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.